182 related articles for article (PubMed ID: 15034804)
1. Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis.
Sargiannidou I; Qiu C; Tuszynski GP
Semin Thromb Hemost; 2004 Feb; 30(1):127-36. PubMed ID: 15034804
[TBL] [Abstract][Full Text] [Related]
2. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
3. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumor dormancy as a function of tumor-mediated paracrine regulation of stromal Tsp-1 and VEGF expression.
Kang SY; Watnick RS
APMIS; 2008; 116(7-8):638-47. PubMed ID: 18834408
[TBL] [Abstract][Full Text] [Related]
5. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
6. Chapter 11. The role of bone marrow-derived cells in tumor angiogenesis and metastatic progression.
Papaspyridonos M; Lyden D
Methods Enzymol; 2008; 444():255-69. PubMed ID: 19007668
[TBL] [Abstract][Full Text] [Related]
7. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
8. Platelets and angiogenesis in malignancy.
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2004 Feb; 30(1):95-108. PubMed ID: 15034801
[TBL] [Abstract][Full Text] [Related]
9. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A.
Hong S; Chang SY; Yeom DH; Kang JH; Hong KJ
Anticancer Drugs; 2007 Oct; 18(9):1005-14. PubMed ID: 17704650
[TBL] [Abstract][Full Text] [Related]
11. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1.
Yano K; Kadoya K; Kajiya K; Hong YK; Detmar M
Br J Dermatol; 2005 Jan; 152(1):115-21. PubMed ID: 15656811
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Davis DW; Takamori R; Raut CP; Xiong HQ; Herbst RS; Stadler WM; Heymach JV; Demetri GD; Rashid A; Shen Y; Wen S; Abbruzzese JL; McConkey DJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):678-89. PubMed ID: 15701856
[TBL] [Abstract][Full Text] [Related]
13. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet function: does it offer a chance of better cancer progression control?
Sierko E; Wojtukiewicz MZ
Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
[TBL] [Abstract][Full Text] [Related]
15. Tumour-associated angiogenesis in human colorectal cancer.
Rmali KA; Puntis MC; Jiang WG
Colorectal Dis; 2007 Jan; 9(1):3-14. PubMed ID: 17181841
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system and matrix metalloproteinases in angiogenesis and tumor progression.
Engelse MA; Hanemaaijer R; Koolwijk P; van Hinsbergh VW
Semin Thromb Hemost; 2004 Feb; 30(1):71-82. PubMed ID: 15034799
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
Affara NI; Robertson FM
In Vivo; 2004; 18(5):525-42. PubMed ID: 15523889
[TBL] [Abstract][Full Text] [Related]
19. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
20. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
